• Nie Znaleziono Wyników

The Voice of the Editor-in-Chief

N/A
N/A
Protected

Academic year: 2022

Share "The Voice of the Editor-in-Chief"

Copied!
2
0
0

Pełen tekst

(1)

1

The Voice of the Editor-in-Chief

Dear Colleagues,

The 5th Conference of the Clinical Diabetology jour- nal was held on 17 and 18 June 2016 in Warsaw. The conference brought together a group of distinguished lecturers and almost 500 participants — physicians dealing in their everyday practice with carbohydrate metabolism disturbances. During this two-day meeting, many topic covering the aspects which have significant implications for clinical practice were discussed:

• Are statins a sufficient solution in diabetic patients with atherogenic dyslipidaemia?

• Type1 diabetes — is it so obvious?

• Patients with cardiovascular disease and diabetes

— new procedures in cardiology

• Hypoglycaemia in diabetes — a threat for the heart and brain?

• Prediabetes — who should be screened and who should be treated?

• Pregnancy — a diabetologist’s point of view

• Searching for the optimization of type 2 diabetes management — are we on eve of the change in the sequence of oral drugs administration?

• Ischaemic stroke — does diabetes influence thera- peutic decisions?

The formula of the meeting has been changed, which, similarly to modifications of the journal itself, aimed at increasing its scientific value and its impact on challenging therapeutic decisions and, subsequently, at improving the quality of life of our patients. Hereby, I would like to thank the Publisher, Via Medica, the Main Board of the Polish Diabetes Association and all its members and friends who contributed to unques- tionable success of the conference.

Enjoy your reading

Editor-in-Chief

Prof. Janusz Gumprecht

(2)

Cytaty

Powiązane dokumenty

„Rodzina w systemie wsparcia społecznego i pomocy osobom z problemem alkoholowym”, zorganizowana przez Pracownię Pedagogiki Specjalnej, w ramach realizowanego

Przekazywał nam też hoj- nie swoje wiadomości, choć byliśmy w wieku, kiedy na ogół nie docenia się wielu skarbów pchających się w ręce.. Na szczęście zapamiętałam zdradzone

Leptin plays a crucial role in the maintenance of body weight and glucose homeostasis hrough central and peripheral pathways, in- cluding regulation of insulin secretion by pancreatic

among patients with acromegaly, disorders of carbohydrate tolerance occur in more than half of the cases, which confirms the need for active screening in this group of patients,

Professor Janusz Gumprecht has excellently developed the journal — it appears regularly, contains more and more papers from outside Poland, is included in the Web of Science

Just before the publication of this issue of “Cli- nical Diabetology”, the largest diabetes meeting in the world — 79 th Scientific Sessions of the American Diabetes

Although more than 3,500 years have passed since the first description of the symptoms of diabetes in the Egyptian papyrus dated to around 1550 BC, diabetes is still

differences in the frequency, causes and duration of hospitalization of children with diabetes in different regions of Poland, which implies the need to ensure uniform access

Another challenge is effective and safe use of antidiabetic drugs to minimize side effects, improve adherence, increase the acceptance of the disease and reduce the risk

At the beginning of October, annual meeting of European Association for the Study of Diabetes (EASD) will be held in Berlin, and one of the most awaited events during this

Among papers included in this issue of “Clinical Diabetology”, it is worth paying attention to a multi- centre study conducted in 2013–2017 in women with type 1 diabetes who,

As the practical management of patients with diabetes should be based primarily on knowledge derived from Evidence Based Medicine (EBM), the reference to the EBM

I would like to draw your attention to the problem of diabetes care quality discussed by researchers from Libya, an interesting case report of the use of hydroxychloroquine in type

Many interesting reports presented during the Congress addressed, among others, epidemiology, new possibilities of molecular biology, measurable effects of translating basic

Following the publication of the results of already completed Cardiovascular Outcome Trials (CVOTs) on new molecules used in the treatment of diabetes, there is no doubt that

In the InTandem3 study (Study to Evaluate the Safety of So- tagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycaemic Control With Insulin Therapy Alone) with

In addition to attending the scientific meetings, I also encourage you to read the latest issue of the “Clinical Diabetology”, where, among a number of interesting articles, I would

Considering the above, I would like to draw your attention to two of many interesting articles published in the last issue of Clinical Diabetology: the paper presenting

In accordance with other diabetic organizations (the American Diabetes Association — ADA, the National Institute for Health and Care Excellence — NICE), glycaemic goals has

Here, it should be mentioned that also the LEADER trial, that assessed cardiovascular safety of one of GLP-1 agonists, liraglutide, in the population of type 2 diabetes

Despite recent advances in medicine, introduction of new hypoglycaemic drugs and the fact that more than 3.500 years have passed since the earliest known record of diabetes

At the same time, we intend to continue the educational function of the journal and we do not want to hinder the access to its content for the readers; therefore, we decided

This change is a result of systematic de- velopment of our journal aiming at further increasing its presence and importance on the international arena and striving to